Brown Advisory’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,212
Closed -$445K 1267
2023
Q4
$445K Hold
10,212
﹤0.01% 965
2023
Q3
$390K Hold
10,212
﹤0.01% 969
2023
Q2
$420K Hold
10,212
﹤0.01% 948
2023
Q1
$586K Hold
10,212
﹤0.01% 878
2022
Q4
$573K Hold
10,212
﹤0.01% 875
2022
Q3
$432K Hold
10,212
﹤0.01% 893
2022
Q2
$551K Sell
10,212
-31
-0.3% -$1.86K ﹤0.01% 828
2022
Q1
$658K Buy
10,243
+2,579
+34% +$170K ﹤0.01% 800
2021
Q4
$513K Buy
7,664
+39
+0.5% +$2.64K ﹤0.01% 870
2021
Q3
$522K Sell
7,625
-2,587
-25% -$183K ﹤0.01% 820
2021
Q2
$697K Sell
10,212
-3,600
-26% -$255K ﹤0.01% 782
2021
Q1
$954K Sell
13,812
-5,998
-30% -$406K ﹤0.01% 715
2020
Q4
$1.29M Sell
19,810
-453,954
-96% -$24.4M ﹤0.01% 609
2020
Q3
$22.4M Buy
473,764
+16,903
+4% +$804K 0.05% 224
2020
Q2
$21.5M Sell
456,861
-312,835
-41% -$15.4M 0.05% 219
2020
Q1
$34.4M Sell
769,696
-958,020
-55% -$50.3M 0.11% 149
2019
Q4
$101M Buy
1,727,716
+47,778
+3% +$2.84M 0.26% 83
2019
Q3
$101M Buy
1,679,938
+232,543
+16% +$13.9M 0.28% 69
2019
Q2
$80.8M Buy
1,447,395
+147,687
+11% +$7.61M 0.23% 82
2019
Q1
$72.4M Buy
1,299,708
+287,435
+28% +$14.6M 0.21% 91
2018
Q4
$45.7M Buy
+1,012,273
New +$55.5M 0.15% 131

Other funds holding IART

Brown Advisory's IART Position: Q1 2024 in Review

Brown Advisory sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 10,212 shares — an estimated $445K sold.

Brown Advisory first reported a position in IART in Q4 2018 and held it in 21 quarters. The position peaked at $101M in Q3 2019. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Brown Advisory reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Brown Advisory sold 10,212 Integra LifeSciences shares in Q1 2024, an estimated $445K.
  • Brown Advisory first reported a position in Integra LifeSciences in Q4 2018 and held it in 21 quarters.
  • Brown Advisory's Integra LifeSciences position peaked at $101M in Q3 2019.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.